Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer.
Baishen ZhangJing ChenHui YuMeichen LiMuyan CaiLi-Kun ChenPublished in: Journal of inflammation research (2024)
A high baseline PNI might be associated with improved prognosis and the occurrence of IRAEs in ES-SCLC patients treated with first-line chemoimmunotherapy.